NIBSC标准品 热卖抗原抗体标品 英国国家生物标准与检定所标品
其他热卖抗原抗体：
13/242 FEIBA Concentrate 2nd NIBSC Working Reference Standard
92/680 Serum amyloid A protein. WHO International Standard
92/644 Interleukin-1 receptor antagonist (Human rDNA derived)
05/112 Low Molecular Weight Heparin for Molecular Weight Calibration(2nd International Standard)
08/282 Follicle-Stimulating Hormone, human, recombinant, for bioassay (2nd International Standard)
10/266 4th WHO International Standard for HBV DNA for NAT
14/150 Hepatitis C virus (HCV) For nucleic acid amplification techniques (5th International standard 2015)
13/146 C-Peptide, Human. 1st International Standard
93/556 Nerve Growth Factor (Human, rDNA derived)
16/194 HIV-1 RNA 4th International Standard
AFP(72/225) Alpha-Foetoprotein
83/500 Insulin, Human
09/296 1st International Standard for human Proinsulin
83/573(84/500) Prolactin, Human
96/668 Prostate-Specific Antigen Free
10/152 Candidate HIV-1 RNA 3rd International Standard
PPDBOV Purified Protein Derivative (PPD) of Bovine Tuberculin WHO International Standard
PPDA Purified Protein Derivative (PPD) of M Avium Tuberculin WHO International Standard
67/182 Anti-Rubella Serum, Human
12/226 HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard)
93/526 Batroxobin
10/266 (10/264) Hepatitis B Virus for Nucleic Acid Amplification Techniques (3rd WHO International Standard)
07/164 Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard)
09/260 Epstein-Barr Virus (1st International Standard)
B2M Beta-2 Microglobulin
75/595 Blood Coagulation Factor Xa, Bovine
13/100 Activated Blood Coagulation Factor XI (FXIa), Human (1st International Standard)
12/224 HIV-1 NAT subtypes (Main)(2nd International Reference Preparationl)
14/290 4th HCV RNA Genotype Panel for Nucleic Acid Amplification
11/234(75/502) Serum Immunoglobulin E (IgE) Human
88/646 Granulocyte Macrophage Colony Stimulating Factor (Human, rDNA derived) WHO International Standard
87/640 Tumour Necrosis Factor beta (Human, rDNA derived) WHO Reference Reagent
85/506 C-Reactive Protein, Human
92/510 Follicle Stimulating Hormone, Human, recombinant
08/258 Antithrombin, Plasma (3rd International Standard)
66/387 Anti-thyroid Microsome Serum, Human
06/202 HPV 16 DNA
06/206 HPV 18 DNA
94/572 Ferritin, Human, recombinant
RTF/16 Thromboplastin, Human, Recombinant, Plain 5th International Standard 2016
83/575 Follicle Stimulating Hormone, Pituitary
73/601 Carcinoembryonic Antigen (CEA), Human (1st International Reference Preparation)
RAI Anti-rabies Immunoglobulin, Human
80/505 Growth Hormone, Human, Pituitary
RUBI-1-94 Anti-rubella Immunoglobulin, Human
75/551 Chorionic Gonadotrophin beta Subunit, Human
09/162 Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard
81/535(80/552) Luteinizing Hormone, Human, Pituitary
91/530 Epidermal Growth Factor (Human, rDNA derived)
09/264 Fibrinogen Plasma (D)(3rd International Standard)
其他抗原抗体库存：
97/648 Anti-Measles serum
RAI Anti-rabies Immunoglobulin, Human
83/575 Follicle Stimulating Hormone, Pituitary
06/166 Antithrombin Concentrate, Human
90/636 HIV-1 P24 Antigen
08/258 Antithrombin, Plasma (3rd International Standard)
流感抗原现货库存：
09/274 Influenza Virus Infectious NYMC X-185
98/762 Influenza Virus infectious Resvir-14 (H3N2)
90/784 Influenza Virus infectious NIB-26 (H3N2)
05/102 Influenza Virus infectious NYMC BX-7
12/202 Influenza virus infectious NYMC BX-39
00/530 Influenza Virus infectious B/Sichuan/379/99
05/138 Influenza Virus infectious B/Shanghai/361/2002
12/202 Influenza virus infectious NYMC BX-39
13/116 Influenza Antigen A/Texas/50/2012 (NYMC X-223A)
92/734 Influenza Virus infectious A/Beijing/32/92 (H3N2)
92/738 Influenza Virus infectious A/Shanghai/24/90
93/568 Influenza Virus infectious A/Beijing/359/89 (H3N2)
93/572 Influenza Virus infectious A/Guizhou/54/89 (H3N2)
93/686 Influenza Virus infectious A/Shangdong/9/93 (H3N2)
95/758 Influenza Virus infectious A/Wuhan/359/95 (H3N2)
98/778 Influenza Virus infectious A/Sichuan/346/98 (H3N2)
NIBSC 标准品
http:///Standard/
英国国家生物标准与检定所(National Institute for Biological Standards and Control, NIBSC)，同时它又是世界卫生组织WHO的一个国际标准品供应中心，它的核心工作是制备、保存和分发WHO用于检测全球生物制品质量的标准品。NIBSC制备的流感毒株和检测抗原、抗血清标准品，保障了各厂家顺利的研究和生产。
Biotherapeutics
Cytokines and Growth Factors
Endotoxin
Haemostasis
Immunogenicity
Immunoglobulins and immune sera
Protein Hormones and Endocrine Products
Quality Control Reagent
UK Stem Cell Bank
Mouse Embryo Fibroblasts
Diagnostics
Allergen
Anti-Toxins
Blood borne pathogens
Blood Transfusion and Transplantation
Ebola Virus
Genomic Reference Material
Haematinics and Haemoglobin
Haemostasis
Human Papillomavirus
Immunoglobulins and immune sera
Miscellaneous
Parasitology
Parvovirus
Protein Hormones and Endocrine Products
Quality Control Reagent
Zoonosis and livestock diseases
Vaccines
Botulinum
Clostridium
Diphtheria
Ebola Virus
Enteric disease
Haemophilus Influenzae type b (Hib)
Human Papillomavirus
Influenza
JE/Dengue
Malaria
Meningococcal typing and ELISA reagents
MMR
Parasitology
Pertussis
Pneumococcal vaccines
Polio
Quality Control Reagent
Staphylococcal Immune Sera
Tetanus
Tuberculosis
Vaccinia
Yellow Fever
Zoonosis and livestock diseases
00/410 MAPREC assay of poliovirus type 1 (Sabin).100% 480-A, 525-C DNA(1st International Reference Preparation)
International Reference Preparation
00/416 Low Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)
International Reference Preparation
00/418 MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard)
WHO International Standard
00/422 High Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)
International Reference Preparation
00/440 Influenza Antiserum A/Singapore/1/57 (H2)
Influenza Reagent
00/442 Influenza anti B/Yamanashi/166/98 Serum
Influenza Reagent
00/464 Streptokinase (3rd International Standard 2001)
WHO International Standard
00/500 Botulinum Type A-E Antitoxin, Human Serum
Non WHO Reference Material
00/530 Influenza Virus infectious B/Sichuan/379/99
Influenza Reagent
00/542 Influenza anti- A/Chick/Scotland/59 (H5N1) Serum
Influenza Reagent
00/544 Influenza Virus infectious B/Victoria/504/00
Influenza Reagent
00/546 Influenza Antigen B/Johannesburg/5/99
Influenza Reagent
00/552 Influenza Antigen A/Duck/Singapore-Q/F119-3/97 (H5N3)
Influenza Reagent
00/556 Influenza anti-B/Johannesburg/5/99/ Serum
Influenza Reagent
00/562 Hepatitis A Virus for Nucleic Acid Amplification Techniques(2nd International Standard)
WHO International Standard
00/572 Interferon Beta (Human, rDNA, Glycosylated) (3rd International standard)
WHO International Standard
00/574 Interferon Beta SER17 Mutein (Human, rDNA derived)
Non WHO Reference Material
00/576 Interferon Beta (Human, Fibroblast-derived, Glycosylated)
Non WHO Reference Material
00/614 Influenza virus infectious B/Guangdong/120/2000
Influenza Reagent
007SP Human Anti-Pneumococcal capsule Reference Serum (1st International Standard)
WHO International Standard
01/412 Anti-Meningococcal Immunotype L3,7,9 Monoclonal Antibody
Non WHO Reference Material
01/420 Interleukin-17 (Human rDNA derived)(International Reference Reagent)
International Reference Reagent
01/424 Vascular Endothelial Growth Factor, Human rDNA derived
Non WHO Reference Material
01/426 Meningococcal group Y polysaccharide
Non WHO Reference Material
01/428 Meningococcal serogroup W polysaccharide
Non WHO Reference Material
01/450 Influenza anti B/Guangdong/120/2000 Serum
Influenza Reagent
01/452 Influenza anti A/Panama/2007/99 (H3N2) HA serum
Influenza Reagent
01/506 Botulinum type F antitoxin, equine
Non WHO Reference Material
01/508 Botulinum type C antitoxin, equine
Non WHO Reference Material
01/510 Botulinum Antitoxin Equine Type D
Non WHO Reference Material
01/512 Botulinum type G antitoxin, equine
Non WHO Reference Material
01/514 Anti-Meningococcal Serosubtype P1.7 Monoclonal Antibody
Non WHO Reference Material
01/528 Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain] (Panel of 5 ampoules)
International Reference Preparation
01/532 Oral Poliovaccine Sabin Type 3 reference strain (Panel of 5 ampoules)
International Reference Preparation
01/538 Anti-Meningococcal Serosubtype P1.16 mAb
Non WHO Reference Material
01/546 Influenza Antigen B/Guangdong/120/2000
Influenza Reagent
01/572 Anti-D Immunoglobulin(2nd International Standard)
WHO International Standard
01/580 Thrombin, human(2nd International Standard)
WHO International Standard
01/600 Anti-Toxoplasma IgG, Human(International Standard)
WHO International Standard
01/602 Anti-Parvovirus B19, plasma, human(2nd International Standard)
WHO International Standard
01/612 Influenza Virus infectious B/Hawaii/10/01
Influenza Reagent
01/614 Influenza Antigen A/New Caledonia/20/99
Influenza Reagent
02/102 Influenza anti A/Panama/2007/99 Serum
Influenza Reagent
02/144 Anti-Meningococcal Serosubtype P1.15 mAb
Non WHO Reference Material
02/148 Anti-Meningococcal Serosubtype P1.4 mAb
Non WHO Reference Material
02/168 Prekallikrein Activator (PKA), Human(2nd International Standard)
WHO International Standard
02/178 Anti-Meningococcal Serosubtype P1.2 mAb
Non WHO Reference Material
02/180 Anti-Meningococcal Serotype P2.2a mAb
Non WHO Reference Material
02/182 Anti-Japanese Encephalitis Virus Plasma, Human
Non WHO Reference Material
02/184 Anti-Japanese Encephalitis (Anti-JE) Virus Negative Control Plasma, Human
Non WHO Reference Material
02/206 Factor XIII Plasma, Human (1st International Standard)
WHO International Standard
02/210 HIV (antibody), 1st International Reference Panel
International Reference Preparation
02/226 IVIG negative control for use with IVIG + anti-D(International Reference Reagent)
International Reference Reagent
02/228 IVIG + anti-D for use with negative control IVIG(International Reference Reagent)
International Reference Reagent
02/230 Biotinylated Brad-5 (Bio-Brad-5)
Working Standard
02/232 Tetanus Toxoid (Non-Adsorbed)
Non WHO Reference Material
02/254 Insulin-like Growth Factor-1, recombinant, human, for immunoassay(1st International Standard)
WHO International Standard
02/262 Influenza Virus infectious B/Brisbane/32/2002
Influenza Reagent
02/286 Vascular Endothelial Growth Factor 165 (VEGF165)(recDNA, human sequence)(International Reference Reagent)
International Reference Reagent
02/294 Influenza Antiserum A/chick/Italy/1347/99 (H7N1)
Influenza Reagent
02/308 Anti-Meningococcal Serotype P3.4 mAb
Non WHO Reference Material
02/310 Anti-Meningococcal Serotype P3.15 mAb
Non WHO Reference Material
02/318 Botulinum Antitoxin Equine Type E
Non WHO Reference Material
02/320 Anti-Meningococcal Serosubtype P1.3 mAb
Non WHO Reference Material
02/336 Influenza Antigen A/New Caledonia/20/99
Influenza Reagent
02/338 Influenza anti A/Panama/2007/99 Serum
Influenza Reagent
02/342 Protein C Plasma, Human(2nd International Standard)
WHO International Standard
03/104-018 HTLV-1 (antibody) Monitor Sample
CE Marked Material
03/110 Influenza anti B/Shangdong/9/97 Serum
Influenza Reagent
03/114 Anti-Meningococcal Serosubtype P1.1 mAb
Non WHO Reference Material
03/116 Blood Coagulation Factor V, Plasma Human (1st International Standard)
WHO International Standard
03/124 Thrombopoietin ( Human rDNA derived)
Non WHO Reference Material
03/142 Anti-Meningococcal Serosubtype P1.14 mAb
Non WHO Reference Material
03/148 Keratinocyte growth factor (KGF, FGF-7)(24-163)(1st International Reference Reagent)
International Reference Reagent
03/150 Keratinocyte Growth Factor (KGF,FGF-7)(1st International Reference Reagent)
International Reference Reagent
03/152 Anti-HPA-1a (International Standard)
WHO International Standard
03/164 Anti-B minimum potency reference preparation(International Standard)
WHO International Standard
03/178 Vitamin B12, Serum Folate and holoTC (International standard)
WHO International Standard
03/182 Anti-Meningococcal Serotype P3.21 mAb
Non WHO Reference Material
03/188 Anti-A minimum potency reference preparation(International Standard)
WHO International Standard
03/190 Anti-HPA-3a(minimum potency)(International Reference Reagent)
International Reference Reagent
03/192 Thyroid-Stimulating Hormone, Recombinant, Human, for Bioassay (1st International standard)
WHO International Standard
03/198 Influenza Virus infectious A/Kumamoto/102/02
Influenza Reagent
03/200 Interleukin - 18 (Human rDNA derived)(International Reference Reagent)
International Reference Reagent
03/210 Anti-Meningiococcal Serosubtype P1.6 mAb
Non WHO Reference Material
03/212 Influenza anti A/Wyoming/03/03 Serum
Influenza Reagent
03/220 Influenza Antigen A/Wyoming/03/03
Influenza Reagent
03/224 Anti-Meningococcal Serosubtype P1.10 mAb
Non WHO Reference Material
03/226 Anti-Meningococcal Serosubtype P1.5 mAb
Non WHO Reference Material
03/228 Protein S, Plasma, Human(2nd International Standard)
WHO International Standard
03/236 Anti-Meningococcal Serosubtype P1.13 mAb
Non WHO Reference Material
03/242 Influenza anti A/Puerto Rico/8/34 (H1N1) HA Serum
Influenza Reagent
03/244 Influenza Antiserum A/chick/Germany/N/49
Influenza Reagent
03/258 Influenza Antigen A/New Caledonia/20/99 (IVR-116)
Influenza Reagent
03/262 Hepatitis B Surface Antigen subtype adw2, genotype A (International Reference Panel)
International Reference Preparation
04/122 Anti-Meningococcal Serosubtype P1.12 mAb
Non WHO Reference Material
04/132 IVIG + Anti-D for use with negative control IVIG
Non WHO Reference Material
04/140 IVIG Negative Control for use with IVIG & Anti-D
Non WHO Reference Material
04/150 Tetanus Toxoid For Flocculation Test(2nd International Standard)
WHO International Standard
04/160 Influenza Virus infectious NYMC X-147
Influenza Reagent
04/166 TNF-related Apoptosis-Inducing Ligand (trail), Human, rDNA-derived(1st International Reference Reagent)
WHO International Standard
04/170 Influenza Virus infectious A/Wellington/1/2004
Influenza Reagent
04/172 Influenza Virus infectious IVR-139
Influenza Reagent
04/176 Plasmodium falciparum DNA for NAT Assays(1st International Standard)
WHO International Standard
04/198 Anti-Meningococcal Serotype P3.1 mAb
Non WHO Reference Material
04/200 Parathyroid hormone 1-34 ,Recombinant, Human(International Standard)
WHO International Standard
04/202 Influenza Antigen B/ Jiangsu/10/2003
Influenza Reagent
04/214 Influenza Antiserum A/Viet Nam/1194/04 (H5N1)
Influenza Reagent
04/224 Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004
WHO International Standard
04/228 Influenza anti B/ Neuraminidase Serum
Influenza Reagent
04/242 Influenza anti B/Jiangsu/10/2003 HA Serum
Influenza Reagent
04/246 Anti-Meningococcal Serogroup W-135 mAb
Non WHO Reference Material
04/248 Anti-Meningococcal Serosubtype P1.19 mAb
Non WHO Reference Material
04/252 Protein C Concentrate, Human(1st International Standard)
WHO International Standard
04/260 Influenza anti A/New Caledonia/20/99 HA Serum
Influenza Reagent
04/262 Influenza anti A/New York/55/2004 HA Serum
Influenza Reagent
04/264 Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157)
Influenza Reagent
05/102 Influenza Virus infectious NYMC BX-7
Influenza Reagent
05/106 Anti-HPA-1a minimum potency reagent(2nd International Reference reagent)
International Reference Reagent
05/110 Influenza Virus infectious A/California/7/2004
Influenza Reagent
05/112 Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard).
WHO International Standard
05/122 Syphilitic plasma IgG (human)(1st International Standard)
WHO International Standard
05/130 Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005)
WHO International Standard
05/134 Anti-human papillomavirus type 16 serum (1st International Standard)
WHO International Standard
05/138 Influenza Virus infectious B/Shanghai/361/2002
Influenza Reagent
05/162 Alpha-1-Antitrypsin, plasma derived(1st International standard)
WHO International Standard
05/190 Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody
Non WHO Reference Material
05/192 Anti Meningococcal Serotype P2.2b Monoclonal Antibody
Non WHO Reference Material
05/234 Influenza Antigen A/Hiroshima/52/2005 (H3N2) (IVR-142)
Influenza Reagent
05/236 Influenza anti A/Wisconsin/67/2005 Serum
Influenza Reagent
05/242 IVIG, Anti-D and Negative Control Panel
Non WHO Reference Material
05/252 Influenza anti B Neuraminidase Serum
Influenza Reagent
06/108 Influenza Virus infectious IVR-116
Influenza Reagent
06/124 Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 2 (1st International Standard)
WHO International Standard
06/128 Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 3 (1st International Standard)
WHO International Standard
06/140 Pertussis Antiserum(human)1st IS-WHO international Standard.
WHO International Standard
06/142 Pertussis Antiserum (Human) 1st WHO Reference Reagent
International Reference Reagent
06/164 Influenza Virus infectious 1 VR-142
Influenza Reagent
06/166 Antithrombin Concentrate, Human (3rd International Standard)
WHO International Standard
06/170 Influenza Antigen A/New Caledonia/20/99
Influenza Reagent
06/192 Influenza anti A/turkey/Turkey/1/05 (NIBRG-23) HA serum(sheepSH465 & SH466)
Influenza Reagent
06/202 Human Papillomavirus (HPV) Type 16 DNA (1st International Standard)
WHO International Standard
06/206 Human Papillomavirus (HPV) Type 18 DNA (1st International Standard)
WHO International Standard
06/242 Influenza Virus Infectious NYMC X-161B (A/Wisconsin/67/2005 HGR)
Influenza Reagent
07/102 Influenza Antigen A/Solomon Islands/3/2006 (H1N1)(IVR-145)
Influenza Reagent
07/104 Influenza anti A/Solomon Islands/3/2006 (H1N1) (IVR-145) HA Serum
Influenza Reagent
07/112 Influenza Antigen A/turkey/Turkey/1/2005 (H5N1) NIBRG-23
Influenza Reagent
07/132 Influenza Virus infectious B/Malaysia/2506/2004
Influenza Reagent
07/144 Influenza Virus infectious IVR-145,
Influenza Reagent
07/146 Influenza anti A/HongKong/1073/99 like (H9) HA Serum (sheep)
Influenza Reagent
07/148 Influenza anti A/Vietnam/1194/04 (H5N1) HA Serum
Influenza Reagent
07/150 Human Plasma Anti-Influenza H5N1 (1st International Standard)
WHO International Standard
07/164 Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard)
WHO International Standard
07/184 Influenza anti B/Malaysia/2506/2004-HA Serum
Influenza Reagent
07/202 Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent)
International Reference Reagent
07/204 Influenza Virus Infectious NIBRG-60 VE2 25820
Influenza Reagent
07/214 Positive Control for use in flow cytometry cross matching (FCXM)
CE Marked Material
07/216 Diphtheria Toxoid (Adsorbed) (4th International Standard)
WHO International Standard
07/222 RhD/SRY Plasma DNA sensitivity standard (1st International Reference Reagent)
International Reference Reagent
07/226 Influenza Virus Infectious A/New Caledonia/20/99
Influenza Reagent
07/228 Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard”
WHO International Standard
07/246 Influenza Virus Infectious IVR-147
Influenza Reagent
07/268 Influenza Virus Infectious B/Brisbane/3/2007
Influenza Reagent
07/270 BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent)
International Reference Reagent
07/272 BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent)
International Reference Reagent
07/274 BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent)
International Reference Reagent
07/278 Influenza anti A/mallard/Netherlands/12/2000 (H7) HA serum (NIBRG-60) (sheep SH474 AND SH475)
Influenza Reagent
07/286-014 0.05 IU HBsAg Monitor Sample
CE Marked Material
07/288-016 Hepatitis B Surface Antigen British Working Standard 0.2 IU/ml
CE Marked Material
07/290 Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6
Influenza Reagent
07/296-006 Influenza Virus (A/Christchurch/1/2003, H1N1) for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
07/298-006 Influenza Virus (A/Wyoming/3/2003, H3N2) for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
07/300-005 Influenza Virus (B/Jiangsu/10/2003) for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
07/304 Anti-D for assuring operator and test performance
Working Standard
07/306 Anti-A and anti-B in IVIG: Positive control for haemagglutination tests (International Reference Reagent)
International Reference Reagent
07/316 Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.)
WHO International Standard
07/318 Meningococcal Group C Polysaccharide
Non WHO Reference Material
07/328 Unfractionated Heparin (6th I.S.)
WHO International Standard
07/336 Influenza Antigen A/mallard/Netherlands/12/00(H7N3) NIBRG-60
Influenza Reagent
07/338 Influenza antiserum A/Anhui/1/05 (H5)
Influenza Reagent
07/348 Influenza Virus infectious NYMC X-171B
Influenza Reagent
07/350 Blood Coagulation Factor VIII Concentrate (8th I.S.)
WHO International Standard
07/358 Influenza Virus infectious NIB-50
Influenza Reagent
07/362 Influenza Virus infectious IVR-149
Influenza Reagent
07/364 Chorionic Gonadotrophin, (5th International Standard)
WHO International Standard
07/B498-18 QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1
Quality Control Reagent
08/100 Influenza Antigen A/Brisbane/59/2007 (IVR-148) (H1N1)
Influenza Reagent
08/108 Influenza Virus Infectious NIBRG-91
Influenza Reagent
08/118-005 Parainfluenza Virus serotype 3 for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
08/120-006 Human Respiratory syncytial virus A2 for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
08/126 Influenza Anti N1 Neuraminidase Serum SH485
Influenza Reagent
08/138 Influenza Virus Infectious B/Florida/4/2006
Influenza Reagent
08/140 Influenza Antigen B/Florida/4/2006
Influenza Reagent
08/142 Influenza antiserum A/Anhui/1/05 (H5)
Influenza Reagent
08/148 Positive control for Luminex based anti-HLA Class II serology
CE Marked Material
08/150 HIV-2 RNA(1st International Standard)
WHO International Standard
08/154 Influenza Virus Infectious NIBRG-12
Influenza Reagent
08/156 Influenza Virus Infectious NIBRG-23 30060 VE3
Influenza Reagent
08/158 Fragile X Syndrome gDNA (1st International Genetic Reference Panel)
WHO International Standard
08/160 Haemophilia A, Intron-22 inversion, gDNA, (1st International Genetic Reference Panel)
WHO International Standard
08/174-007 Human Coxsackie B4 for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
08/176-005 Parainfluenza Virus serotype 1 for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
08/178-005 Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
08/180-005 Parainfluenza virus serotype 4 for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
08/184 Influenza Antigen B/Malaysia/2506/2004
Influenza Reagent
08/202 Influenza anti A/chick/Hong Kong/G9/1997/(H9) HA serum (NIBRG-94)(H9N1)
Influenza Reagent
08/204 Thyroid Stimulating Antibody (2nd I.S.)
WHO International Standard
08/208 Influenza Antigen Hong Kong/1073/99 (H9N2)
Influenza Reagent
08/210 Influenza anti A/Cambodia/R0405050/2007 (H5) HA serum (NIBRG-86)
Influenza Reagent
08/214 Meningococcal Serogroup C polysaccharide (1st International Standard)
WHO International Standard
08/216 Influenza Antigen A/Cambodia/RO405050/2007 (H5N1)
Influenza Reagent
08/218 Tetanus Toxoid Adsorbed (4th International Standard)
WHO International Standard
08/228 Influenza Antigen A/chick/Hong Kong/G9/1997 (H9N2) NIBRG-91
Influenza Reagent
08/230 Streptodornase (2nd International Standard)
WHO International Standard
08/246 Influenza anti A/Brisbane/10/2007- like HA serum
Influenza Reagent
08/256 C1- Inhibitor, Concentrate (1st International Standard)
WHO International Standard
08/258 Antithrombin, Plasma (3rd International Standard)
WHO International Standard
08/262 C1 Inhibitor (Plasma)(1st International Standard)
WHO International Standard
08/266 Sex Hormone Binding Globulin.(2nd International Standard)
WHO International Standard
08/268 Influenza Antigen A/mallard/England/727/2006 (H2N3)NIBRG-107
Influenza Reagent
08/278 Influenza Antigen A/Brisbane/10/2007-like (Prepared from A/Uruguay/716/2007 (NYMC X-175C))
Influenza Reagent
08/282 Follicle-Stimulating Hormone, human, recombinant, for bioassay (2nd International Standard)
WHO International Standard
08/298 Influenza Virus Infectious B/Brisbane/33/2008 30720 E5
Influenza Reagent
08/300 Influenza Virus Infectious IVR-148
Influenza Reagent
08/304 Influenza virus infectious NYMC X-175C
Influenza Reagent
08/318-007 Human Norovirus GI Working Reagent for Nucleic Acid Amplification Testing
Clinical Virology Network CVN
08/320-007 Human Metapneumovirus Working Reagent for Nucleic Acid Amplification Testing
Clinical Virology Network CVN
08/322-006 Human Parechovirus Working Reagent for Nucleic Acid Amplification Testing
Clinical Virology Network CVN
08/324-005 Human Rhinovirus Genogroup A Working Reagent for Nucleic Acid Amplification Testing
Clinical Virology Network CVN
08/356 Influenza antiserum A/Japan/305/57 (H2)
Influenza Reagent
08/362 Influenza Antigen A/New York/107/2003 (H7N2)NIBRG-109
Influenza Reagent
09/100 Influenza anti A/mallard/England/727/2006 (N3) NA serum (NIBRG-107) (Sheep SH503)
Influenza Reagent
09/110 Parvovirus B19 DNA Nucleic Acid Amplification Technology(NAT) based assays Genotype Panel(1st International Standard)
WHO International Standard
09/112 Negative Control for use in flow cytometry cross matching (FCXM) and anti-HLA serology
CE Marked Material
09/130 Influenza Virus Infectious NIBRG-122
Influenza Reagent
09/132-004 Human Coronavirus 229E Working Reagent for Nucleic Acid Amplification Testing
Clinical Virology Network CVN
09/136 Granulocyte Colony Stimulating Factor (Human, rDNA Derived)(2nd International Standard)
WHO International Standard
09/138 Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR (1st I.S.)
WHO International Standard
09/140 Prader Willi & Angelman Syndromes, Human gDNA,(1st International Genetic Reference Panel)
WHO International Standard
09/148 Influenza anti A/New York/107/2003 (H7) HA serum (Sheep SH504 and SH505)
Influenza Reagent
09/154 Clostridium sordellii (Gas-gangrene) Antitoxin, Equine,(1st International standard)
WHO International Standard
09/162 Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard)
WHO International Standard
09/170 Anti-Meningococcal factor H binding protein variant 1 (JAR4) monoclonal antibody
Non WHO Reference Material
09/172 Blood coagulation Factors II, VII, IX, X Plasma (4th International Standard 2010)
WHO International Standard
09/174 Influenza Antigen A/California/7/09 (H1N1)v (NYMCX-179A)(Cell Derived)
Influenza Reagent
09/182 VWF Factor Concentrate (2nd International Standard)
WHO International Standard
09/184 Influenza Antigen A/Vietnam/1194/2004 (H5N1) NIBRG-14
Influenza Reagent
09/186 Chagas (anti-Trypanosoma cruzi II) antibody in human plasma(1st International Standard)
WHO International Standard
09/188 Chagas (anti-Trypanosoma cruzi I) antibody in Human Plasma (1st International Standard)
WHO International Standard
09/196 Influenza Antigen A/California/7/09 (H1N1)v (NIBRG-121xp) (Egg Derived)
Influenza Reagent
09/222 Human anti-Haemophilus influenzae b reference serum
CE Marked Material
09/234 Transforming Growth Factor-BETA 3 (Human, rDNA derived TGF-? 3) (1st International Standard)
WHO International Standard
09/236 Influenza Virus Infectious IVR-153
Influenza Reagent
09/242 Fibrinogen Concentrate (B)(2nd International Standard)
WHO International Standard
09/260 Epstein-Barr Virus for Nucleic Acid Amplification Techniques(1st International Standard)
WHO International Standard
09/264 Fibrinogen Plasma (D)(3rd International Standard)
WHO International Standard
09/266 GLIAL CELL-DERIVED NEUROTROPHIC FACTOR (GDNF), human, rDNA-derived
Non WHO Reference Material
09/268 Influenza Virus Infectious NIBRG-121xp
Influenza Reagent
09/272 Placental growth factor Ala 21 - Arg 149, human, rDNA-derived (PlGF, PlGF-1)
Non WHO Reference Material
09/274 Influenza Virus Infectious NYMC X-185
Influenza Reagent
09/280 Influenza Virus Infectious NIB-64
Influenza Reagent
09/284 Anti-Human Neutrophil Antibody 1a WHO Reference Reagent
International Reference Reagent
09/296 Pro-Insulin, human (1st International Standard)
WHO International Standard
09/304 Influenza Virus Infectious IVR-155
Influenza Reagent
09/306 Influenza Virus Infectious NIBRG-147
Influenza Reagent
09/308 Influenza Serology Antigen Reagent X-179A (H1N1pdm) for HI Assay
Working Standard
09/310 Influenza Antigen A/Wisconsin/15/09 (H3N2) (NYMCX-183)
Influenza Reagent
09/316 Influenza Anti B Neuraminidase Serum (B/Florida/4/2006)
Influenza Reagent
09/B584-15 QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1
Quality Control Reagent
10/104 Reteplase Reference Material
Non WHO Reference Material
10/120 Influenza Anti A/Brisbane/59/2007 (IVR 148)(H1N1) HA serum
Influenza Reagent
10/128 Diphtheria Polyclonal Antibody
Non WHO Reference Material
10/130 Diphtheria Monoclonal Antibody
Non WHO Reference Material
10/132 Tetanus Polyclonal Antibody
Non WHO Reference Material
10/134 Tetanus Monoclonal Antibody
Non WHO Reference Material
10/136-001 HLA-DRB1 Genotyping Reference Panel
CE Marked Material
10/140 Anti-human papillomavirus[HPV] 18 serum (1st International Standard)
WHO International Standard
10/142 Negative control for Luminex based anti-HLA serology
CE Marked Material
10/164 Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain].
International Reference Reagent
10/168 Oral Poliovaccine Sabin Type 3 reference
International Reference Reagent
10/176 Interleukin-29 (Interferon Lamda 1)
International Reference Reagent
10/178 Endotoxin (3rd International Standard)
WHO International Standard
10/188 Factor VIII Concentrate (13th British Standard).
Working Standard
10/198 Anti-malaria (Plasmodium falciparum) human serum(1st International Reference Reagent)
International Reference Reagent
10/202 Influenza antibody (Human) to A/California/7/2009 'like' (H1N1v) virus (2nd International Standard)
WHO International Standard
10/214 Influenza Anti N2 Neuraminidase Serum SH395 & SH396
Influenza Reagent
10/218 Influenza Anti A/California/7/2009 (N1) NA Serum
Influenza Reagent
10/226 Influenza Virus Infectious IVR-158
Influenza Reagent
10/232 Genomic DNA for blood group genotyping RBC1(AR1R1)(International Reference Reagent)
International Reference Reagent
10/234 Genomic DNA for blood group genotyping RBC12 (ODpsi)(International Reference Reagent)
International Reference Reagent
10/236 Genomic DNA for blood group genotyping RBC4(OR1R2)(International Reference Reagent)
International Reference Reagent
10/238 Genomic DNA for blood group genotyping RBC5(Brr)(International Reference Reagent)
International Reference Reagent
10/242 Toxoplasma gondii DNA Nucleic Acid Amplification Techniques(1st International Standard)
WHO International Standard
10/252 Factor VII Concentrate(2nd International Standard)
WHO International Standard
10/258 Influenza Antigen A/California/7/2009-like(NIB-74)
Influenza Reagent
10/262 Diphtheria Antitoxin Human IgG(1st International Standard)
WHO International Standard
10/266 4th WHO International Standard for HBV DNA for NAT
WHO International Standard
10/272 BCG vaccine of Moreau-RJ sub-strain(1st International Reference Reagent)
International Reference Reagent
10/280 Anti-HLA Control
CE Marked Material
10/286 Follicle Stimulating Hormone, Luteinizing Hormone human, urinary for bioassay(5th International Standard)
WHO International Standard
10/B596-11 QCRHSV1QC1-Anti-HSV1 Quality Control Serum: Sample1
Quality Control Reagent
1050 IPV ELISA MAbs Type 1, 2 and 3 (Type 2; No: 1050)
Non WHO Reference Material
11/106 Influenza Virus infectious A/Perth/16/2009
Influenza Reagent
11/108 Influenza Virus infectious NYMC X-187
Influenza Reagent
11/126 Factors II and X Concentrate (4th International standard)
WHO International Standard
11/130 Influenza Virus Infectious NIBRG-14
Influenza Reagent
11/134 Influenza Antigen A/California/7/2009 (H1N1) Like (A/Brisbane/10/2010- cell derived)
Influenza Reagent
11/170 Erythropoietin, recombinant, for Bioassay (3rd International Standard)
WHO International Standard
11/176 (3rd International Standard) Low Molecular Weight Heparin
WHO International Standard
11/184 High Molecular Weight Urokinase(2nd International Standard)
WHO International Standard
11/206 Influenza anti-A/Perth/16/2009 HA Serum
Influenza Reagent
11/210 Anti-human CD4 FITC conjugated 0.5ml
CE Marked Material
11/214 Blood Group Genotyping Reference Panel ((International Reference Reagent)
International Reference Reagent
11/216 Chagas Antibody Reference Panel ( 1st International Standard)
WHO International Standard
11/218-001 MLH1/MSH2 Exon Copy Number Reference Panel
CE Marked Material
11/222 Influenza Virus Infectious NIB-79
Influenza Reagent
11/226 Influenza Virus Infectious A/Victoria/361/2011
Influenza Reagent
11/232 Influenza Virus Infectious B/Texas/6/2011
Influenza Reagent
11/234 Immunoglobulin E(IgE) human serum (3rd International Standard)
WHO International Standard
11/242-001 Viral Multiplex Reference
Non WHO Reference Material
11/244 Influenza Virus Infectiious NYMC BX-49
Influenza Reagent
11/B604-02 QCRFLUAH5QC1 Influenza H5 PC1
Quality Control Reagent
11/B606-07 QCRNEGQC1-Negative Quality Control Serum: Sample1
Quality Control Reagent
11/B608-03 QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1
Quality Control Reagent
12/100 Influenza Virus Infectious NYMC X-217
Influenza Reagent
12/104 International Standard for IPV 12/104 (3rd International Standard)
WHO International Standard
12/106 Influenza Antigen B/Hubei-Wujiagang/158/2009 (NYMCBX-39)
Influenza Reagent
12/110 Influenza Antigen B/Wisconsin/1/2010 (cell derived)
Influenza Reagent
12/112 Influenza Antigen A/Victoria/210/2009 (H3N2) (NYMCX-187)
Influenza Reagent
12/114 Influenza Antigen A/Victoria/361/2011 (H3N2) (IVR-165)
Influenza Reagent
12/116 Influenza anti-A/Victoria/361/2011-like HA serum
Influenza Reagent
12/118 Influenza anti-B/Wisconsin/1/2010-like HA serum
Influenza Reagent
12/122 Influenza virus infectious A/turkey/Italy/3889/1999
Influenza Reagent
12/154 Tumour Necrosis Factor alpha (human rDNA derived)(3rd International Standard)
WHO International Standard
12/176 Methylated Human Serum Albumin (mHSA)
Non WHO Reference Material
12/188 Pegylated Granulocyte Colony Stimulating Factor (Human, rDNA derived) (International Standard)
WHO International Standard
12/198 Influenza virus infectious B/Wisconsin/1/2010 34490 E5
Influenza Reagent
12/202 Influenza virus infectious NYMC BX-39
Influenza Reagent
12/204 Influenza Virus infectious IVR-165
Influenza Reagent
12/208 Parvovirus B19 (3rd International Standard)
WHO International Standard
12/224 HIV-1 NAT subtypes (Main)(2nd International Reference Panel Preparation)
International Reference Preparation
12/226 HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard)
WHO International Standard
12/252 ADAMTS 13 Plasma (1st International Standard)
WHO International Standard
12/282 Diphtheria Toxin 1Lf/ml
Non WHO Reference Material
12/284 Anti-meningococcal serogroup Y monoclonal antibody
Non WHO Reference Material
12/290 Influenza Virus Infectious B/Brisbane/36/2012
Influenza Reagent
12/294 Influenza Virus Infectious NYMC BX-51C
Influenza Reagent
12/298 Influenza Virus Infectious A/Texas/50/2012
Influenza Reagent
12/306 Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP)(2nd International Standard)
WHO International Standard
12/B611-03 Anti-VZV Quality control serum: Sample 1 QCRVZV IgM QC1
Quality Control Reagent
12/B612-05 QCRRUBIgMQC1-Anti-Rubella IgM Quality Control Serum: Sample 1
Quality Control Reagent
12/B613-06 QCRRUBQC2-Anti-Rubella: Quality Control Serum: Sample 2
Quality Control Reagent
13/100 Activated Blood Coagulation Factor XI (FXIa), Human (1st International Standard)
WHO International Standard
13/106 Influenza Antigen B/Massachusetts/02/2012
Influenza Reagent
13/108 Anti-Meningococcal serogroup B monoclonal antibody
Non WHO Reference Material
13/112 Influenza Antigen A/Texas/50/2012 (NYMC X-223)
Influenza Reagent
13/116 Influenza Antigen A/Texas/50/2012 (NYMC X-223A)
Influenza Reagent
13/122 Erythropoietin Antibody Reference Panel Negative Control Antibody (1st WHO Reference Panel)
WHO International Standard
13/126 Influenza anti-B/Brisbane/60/2008-like HA serum
Influenza Reagent
13/132 Antibodies, Human, to Toxoplasma gondii (4th International Standard).
WHO International Standard
13/134 Influenza Antigen B/Massachusetts/02/2012 (Egg derived)
Influenza Reagent
13/146 C-Peptide, Human (1st International Standard).
WHO International Standard
13/152 Influenza Antigen B/Massachusetts/02/2012 (cell derived)
Influenza Reagent
13/162 Influenza Antigen A/Texas/50/2012 (NYMC X-223A) (Cell derived)
Influenza Reagent
13/164 Influenza Antigen A/California/7/2009 (H1N1pdm)(NYMC X-179A)
Influenza Reagent
13/166 Influenza anti-A/Anhui/1/2013 (N9) NA Serum
Influenza Reagent
13/168-002 Human Measles Mvi/Moscow Rus/1988 Genotype A Virus for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
13/172 Lupus Anticoagulant (1st International Reference Panel)
International Reference Preparation
13/176 Influenza Virus Infectious NIBRG-88
Influenza Reagent
13/178 Influenza Anti-A/Texas/50/2012-like HA Serum
Influenza Reagent
13/182 Influenza Anti-B/Massachusetts/02/2012-like HA Serum
Influenza Reagent
13/198 Influenza Virus Infectious NYMC X-181
Influenza Reagent
13/200 Influenza Virus Infectious NIB-74
Influenza Reagent
13/202 Influenza Virus Infectious NIB-74xp
Influenza Reagent
13/204 TNF Rec II- FC Fusion protein (1st International Standard)
WHO International Standard
13/206 Plasmin (4th International Standard)
WHO International Standard
13/212 Diphtheria Toxoid for use in Flocculation Test (3rd International Standard)
WHO International Standard
13/214 HIV-1 Circulating Recombinant Forms RNA (1st International Reference Panel)
International Reference Preparation
13/216 Anti-meningococcal factor H binding protein variant 1 (JAR5) monoclonal
Non WHO Reference Material
13/218 Polio Anti Sabin type 1 (inactivated) Serum
Non WHO Reference Material
13/220 Polio Anti Sabin type 2 (inactivated) serum
Non WHO Reference Material
13/222 Polio Anti Sabin type 3 (inactivated) serum
Non WHO Reference Material
13/224 Influenza virus Infectious NIB-85. 36210 E5
Influenza Reagent
13/228 Influenza Virus Infectious. A/Almaty/2958/2013. 35790 E4
Influenza Reagent
13/234 Influenza antigen B/Brisbane/60/08
Influenza Reagent
13/238 Anti-EV71 serum LOW (WHO International Reference Reagent)
WHO International Standard
13/242 FEIBA Concentrate 2nd NIBSC Working Reference Standard
Working Standard
13/246 Meningococcal serogroup A polysaccharide (1st WHO International Standard).
WHO International Standard
13/248 Influenza virus infectious NIBRG-267
Influenza Reagent
13/250 Influenza Virus Infectious NIBRG-268
Influenza Reagent
13/252 Influenza virus infectious NYMC X-223A
Influenza Reagent
13/256 Influenza virus infectious. NYMC x-233
Influenza Reagent
13/258 Influenza virus infectious NYMC X-233A
Influenza Reagent
13/264 Influenza Virus Infectious NYMC X-223
Influenza Reagent
13/B627-05 QCRMALQC1-Anti-Malaria Quality Control Serum: Sample1
Quality Control Reagent
13/B629-05 QCRHBeQC1-Anti-HBe Quality Control Serum: sample1
Quality Control Reagent
13/B631-05 QCRHBsGQC1-HBsAg Quality Control Serum: Sample1
Quality Control Reagent
13/B634-04 QCRHAVIgMQC2 IgM Anti-HAV Quality Control Serum: Sample2
Quality Control Reagent
13/B636-05 QCRHIV1QC2- Anti-HIV 1: Quality Control Serum: Sample 2
Quality Control Reagent
13/B640-02 QCRHIV1QC5 - Anti-HIV-1 Quality Control Reagent Sample 5
Quality Control Reagent
13/B642-06 QCRHSV2QC1-Anti-HSV2 Quality Control Serum: Sample 1
Quality Control Reagent
13/B644-03 QCRHIV1QC3-Anti-HIV1:Quality Control Serum:Sample 3
Quality Control Reagent
13/B650-02 QCRCMVQC1- Anti CMV: Quality Control Serum: Sample 1
Quality Control Reagent
14/106 Influenza virus infectious. NYMC BX-51B
Influenza Reagent
14/114 JC Virus (JCV) DNA (1st International Standard)
WHO International Standard
14/116 Influenza virus infectious NYMC X-179A
Influenza Reagent
14/118 Influenza virus infectious B/Massachusetts/2/2012
Influenza Reagent
14/140 1st International Standard for Anti EV71 Serum Human
WHO International Standard
14/144 Influenza anti-N2 Neuraminidase serum (A/Victoria/361/2011)
Influenza Reagent
14/146 Influenza Antigen B/Brisbane/60/2008 (NYMCBX-35)(Cell Derived)
Influenza Reagent
14/148 Human Blood Factor IX Concentrate (5th International Standard).
WHO International Standard
14/150 Hepatitis C virus (HCV) For nucleic acid amplification techniques (5th International standard 2015)
WHO International Standard
14/156 Meningococcal group X polysaccharide (1st WHO International Standard)
WHO International Standard
14/160 High titre anti-A in IVIG working reference reagent
Working Standard
14/174 Botulinum Type A Antitoxin, Equine
Non WHO Reference Material
14/198-003 HBV,HCV,HIV Multiplex
CE Marked Material
14/200 Influenza Antigen A/Puerto Rico/8/34 (HINI)
Influenza Reagent
14/204 Influenza Virus Infectious B/Brisbane/9/2014
Influenza Reagent
14/206 Influenza virus infectious NYMC X-247
Influenza Reagent
14/212 BK Virus (BKV)(1st International Standard)
WHO International Standard
14/224 Influenza virus infectious. A/Switzerland/9715293/2013
Influenza Reagent
14/226 Influenza Virus Infectious A/South Australia/55/2014
Influenza Reagent
14/228 Influenza Virus Infectious A/Stockholm/6/2014
Influenza Reagent
14/230 Influenza Virus Infectious. A/Norway/466/2014
Influenza Reagent
14/232 Influenza Virus Infectious IVR-175
Influenza Reagent
14/240-005 British Working Standard for Anti-HCV
CE Marked Material
14/242-003 Anti-HCV (1 in 8 dilution)(British Working Standard)
CE Marked Material
14/246 Influenza Virus Infectious NIBRG-301
Influenza Reagent
14/254 Influenza Antigen A/Switzerland/9715293/2013 (NIB88)
Influenza Reagent
14/274 Influenza Antigen B/Brisbane/9/2014 (Egg Derived)
Influenza Reagent
14/290 4th HCV RNA Genotype Panel for Nucleic Acid Amplification
Non WHO Reference Material
14/300 High titre anti-A and anti-B in serum (WHO Reference Reagent).
WHO International Standard
14/306 Influenza Virus Infectious NYMC X-243 40180 E13
Influenza Reagent
14/308 Influenza Virus Infectious IVR-178 40200 E7
Influenza Reagent
14/312 Influenza Virus Infectious B/Phuket/3073/2013
Influenza Reagent
14/314 Influenza Virus Infectious NIB-88
Influenza Reagent
14/318 Influenza Anti NIBRG-301 (H5) HA Serum (Sheep SH624 and SH625)
Influenza Reagent
14/320 Influenza Virus Infectious B/Utah/9/2014
Influenza Reagent
14/322 Influenza Virus Infectious NIB-91
Influenza Reagent
14/B651-02 QCRTHBcQC2-Total Anti-HBc Quality Control Serum: Sample2
Quality Control Reagent
14/B653-01 QCRHIV2QC3- Anti HIV2: Quality Control Serum: Sample 3
Quality Control Reagent
14/B654-03 QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample 1
Quality Control Reagent
14/B655-03 QCRVZVQC1-Anti VZV: Quality Control Serum: Sample 1
Quality Control Reagent
15/100 Influenza Antigen B/Utah/9/2014 (Cell Derived)
Influenza Reagent
15/104 Influenza Antigen A/South Australia/55/2014 Cell derived
Influenza Reagent
15/106 Ancrod
WHO International Standard
15/130-001 Clinical Virology Multiplex I: Immunodeficiency panel working reagent for Nucleic Acid Amplification Tests (NAT)
Clinical Virology Network CVN
15/134 Influenza Anti-A Switzerland/9715293/2013-Like HA serum
Influenza Reagent
15/136 EBOV RNA NP-VP35-GP in-run control
International Reference Reagent
15/138 EBOV RNA VP40-L in-run control
International Reference Reagent
15/140 Batroxobin
Non WHO Reference Material
15/146 Influenza Virus Infectious B/Brisbane/60/2008
Influenza Reagent
15/148 Influenza Virus Infectious NIB-92
Influenza Reagent
15/150 Influenza anti-B/Phuket/3073/2013 HA serum
Influenza Reagent
15/154 Influenza Virus Infectious NIB-93
Influenza Reagent
15/158 Influenza Virus Infectious NYMC X-263
Influenza Reagent
15/160 Influenza Virus Infectious NIBRG-306
Influenza Reagent
15/174 Anti-dsDNA serum
Non WHO Reference Material
15/180 Blood Coagulation Factor XI, Plasma Human 2nd IS
WHO International Standard
15/182 7th British Working Standard for Blood Coagulation Factors II, IX, X Concentrate
Working Standard
15/184 Influenza Virus Infectious NYMC X-263B
Influenza Reagent
15/188 Influenza Virus Infectious NYMC X-263A
Influenza Reagent
15/192 Influenza Virus Infectious A/Hong Kong/4801/2014
Influenza Reagent
15/194 Influenza Virus Infectious NYMC X-257A
Influenza Reagent
15/196 Influenza Virus Infectious NYMC X-261
Influenza Reagent
15/212 Influenza Virus Infectious NYMC BX-53C
Influenza Reagent
15/220 Anti-EBOV plasma, human (WHO Reference Reagent)
International Reference Reagent
15/222 EBOV RNA NP-VP35-GP (WHO Reference Reagent)
International Reference Reagent
15/224 EBOV RNA VP40-L (WHO Reference Reagent)
International Reference Reagent
15/234 Influenza Virus Infectious B/Texas/2/2013 41340 E7
Influenza Reagent
15/238 Influenza Antigen A/New Caledonia/71/2014 (NYMCX-257A)(Egg derived antigen)
Influenza Reagent
15/240 Erythropoietin Antibody Reference Panel A (1st WHO Reference Panel)
WHO International Standard
15/242 Erythropoietin Antibody Reference Panel B (1st WHO Reference Panel)
WHO International Standard
15/248 Influenza Anti A/Anhui/1/2013 (H7) HA Serum (Sheep SH644 & SH645)
Influenza Reagent
15/250 Influenza Virus Infectious NYMC BX-31
Influenza Reagent
15/252 Influenza Virus Infectious A/California/7/2009
Influenza Reagent
15/262 Anti- EBOV Convalescent Plasma Pool - Sierra Leone (International Reference Reagent)
International Reference Reagent
15/274 Influenza Virus Infectious NYMC BX-59A
Influenza Reagent
15/294 Influenza virus infectious NYMC BX-59B
Influenza Reagent
15/298 Influenza Virus Infectious B/Brisbane/46/2015
Influenza Reagent
15/300 Influenza Virus Infectious NYMC BX-35 41950 E11
Influenza Reagent
15/312 Influenza Anti-B/Brisbane/60/2008 HA Serum
Influenza Reagent
15/B658-03 QCRLYMEQC1 - Anti-Lyme QC1
Quality Control Reagent
15/B661-04 QCRLYMEIgMQC1 - IgM Anti-Lyme QC1
Quality Control Reagent
15/B664-02 QCRMUMPSQC1 - Anti-Mumps Quality Control Reagent Sample 1
Quality Control Reagent
15/B667-03 QCRMEASQC1 Anti-MeaslesQC1
Quality Control Reagent
15/B669-02 QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1
Quality Control Reagent
15/B671-02 QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1
Quality Control Reagent
15/B673-02 QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1
Quality Control Reagent
15/B675-03 QCRSYPHQC2-Anti-Syphilis Quality Control Serum: sample2
Quality Control Reagent
15/B678-02 QCRPARVB19QC1 Anti-Parvovirus B19QC1
Quality Control Reagent
15/B680-01 QCRHBsQC1- Anti HBs Quality Control Serum: Sample 1
Quality Control Reagent
16/104-001 Norovirus GII Working reagent for Nucleic Acid Amplification Techniques
Clinical Virology Network CVN
16/106 Influenza antigen A/California/7/09 (H1N1) (NYMC-X181)
Influenza Reagent
16/108 Influenza Virus Infectious A/PR/8/34
Influenza Reagent
16/110-001 Zika Virus Working Reagent for Nucleic Acid Amplification Testing (NAT)
Clinical Virology Network CVN
16/114 Influenza anti - A/California/7/09 HA serum
Influenza Reagent
16/118 Influenza Antigen B/Brisbane/60/2008 (NYMC BX-35) (Egg Derived)
Influenza Reagent
16/120 WHO 1st International Reference Panel for Genomic JAK2 V617F
WHO International Standard
16/124-001 Zika Virus run Control (NAT)
Clinical Virology Network CVN
16/158 Influenza Antigen B/Phuket/3073/2013
Influenza Reagent
16/166 Diphtheria Antitoxin Equine DI.
WHO International Standard
16/182 Influenza Anti-A/Hong Kong/4801/2014-like HA Serum
Influenza Reagent
16/192 Influenza Anti-B/Brisbane/60/2008 HA serum
Influenza Reagent
16/194 HIV-1 RNA (4th International Standard)
WHO International Standard
16/200 Influenza Virus Infectious NIB-58
Influenza Reagent
16/208 Influenza Virus Infectious NIB-97 42090 E7
Influenza Reagent
16/238 Influenza Antigen A/Anhui/1/2013 (NIBRG-268) (H7N9)
Influenza Reagent
16/242 Influenza Virus Infectious NIB-98 42110 E7
Influenza Reagent
16/248 Influenza Virus Infectious NYMC X-275 42020 E11
Influenza Reagent
16/268 Influenza Virus Infectious X-273
-----------------------------------------------------------
-----------------------------------------------------------
短型玻璃巴斯德吸管,长型玻璃巴斯德吸管,加长巴氏吸管,巴斯德滴管,巴氏滴管,取样管,吸管消毒桶,吸管灭菌桶,移液管消毒罐,滴管灭菌罐,硅胶胶头,吸管胶头,滴管皮头,硅胶吸球,硅胶头,硅胶帽,巴斯德管头,一次性塑料巴斯德吸管,定制玻璃巴斯德吸管
-----------------------------------------------------------
标准品,对照品,NIBSC标准品,抗原,***,标品,英国***生物标准与检定所标品,美国药典,USP,欧洲药典,EP,加拿大TRC,中检所
-----------------------------------------------------------
聚乙二醇修饰化学和PEG修饰剂选择指南
移液器的日常清洗和维护***
样品瓶和隔垫的选择指南
http:///news/
欢迎致电垂询了解更多详情。
************************************************************
http:///
Tel: 021-37773473,18017917942,18019112618
QQ: 1524395163,55050959,26255569
微信：yarebio801，Xueningjinjin，snailer7942
************************************************************